Project Details
Description
Our data suggests a novel hypothesis whereby APP processing through endolysomal pathways acts as a sensor of pathogens that exploit the endocytic or exocytic machinery of the cell, which we will test in Aim 1. Our data also shows that novel compounds termed secretase modulators (GSM’s) can regulate APP processing to both inhibit HIV-1 replication in macrophages/microglia and to suppress neurotoxic effects of amyloids, which we will test in Aim 2.
Status | Active |
---|---|
Effective start/end date | 4/1/23 → 3/31/28 |
Funding
- National Institute of Neurological Disorders and Stroke (5R01NS131094-02)
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.